...
【24h】

Determination of naproxen in human urine by solid-phase microextraction coupled to liquid chromatography.

机译:固相微萃取-液相色谱法测定人尿中的萘普生。

获取原文
获取原文并翻译 | 示例
           

摘要

An SPME-LC-UV method for the determination of the non-steroidal anti-inflammatory drug (NSAID) naproxen and, after hydrolysis, its glucuronide in human urine samples was developed for the first time using a carbowax/templated resin (CW/TPR-100)-coated fibre. The procedure required a very simple sample pre-treatment, an isocratic elution, and provides a highly selective extraction. All the aspects influencing adsorption (extraction time, temperature, pH and salt addition) and desorption (desorption and injection time and desorption solvent mixture composition) of the analyte on the fibre have been investigated. The linear range investigated in urine was 0.2-20 microg/ml (that covers the typical naproxen urinary concentration) and almost quantitative recoveries were obtained. Within-day and between-days R.S.D.% in urine were 4.5 and 6.0, respectively. The LOD and LOQ in spiked urine were 0.03 and 0.20 microg/ml, well below the usual naproxen urinary level.
机译:SPME-LC-UV方法首次使用碳纤维/模板树脂(CW / TPR)建立了测定非甾体抗炎药(NSAID)萘普生的方法,水解后在人尿液样品中测定了葡糖醛酸。 -100)涂层的纤维。该过程需要非常简单的样品预处理,等度洗脱,并提供高度选择性的提取。研究了影响分析物在纤维上的吸附(萃取时间,温度,pH和盐添加)和脱附(脱附和注入时间以及脱附溶剂混合物组成)的所有方面。尿液研究的线性范围为0.2-20微克/毫升(涵盖典型的萘普生尿液浓度),几乎可以定量回收。日内和日间尿中R.S.D.%分别为4.5和6.0。加标尿液的LOD和LOQ分别为0.03和0.20 microg / ml,远低于萘普生通常的尿液水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号